Across the cagrilintide clinical program, the dominant tolerability issues have been gastrointestinal: nausea, reduced appetite, constipation, and, less commonly, vomiting a profile shared with pramlintide and with GLP-1 agonists, and mechanistically expected from a compound that slows the stomach and engages the area postrema
South Lincoln's commercial corridors have newer medical offices
We provide ongoing support and regular assessments to adapt your plan as needed and ensure continued progress towards your weight goals
It is crucial that you never freeze the pen
In phase 2 trials, orforglipron achieved up to 14.7% mean weight reduction at 36 weeks in adults with obesity or overweight, in line with the mid-teens weight reduction from NVOs higher dose oral semaglutide , as well as the injectables currently in the market
Proper storage helps maintain its effectiveness and extends its shelf life up to 36 months